Drug Store News8d
Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion
The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
Morningstar1mon
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Morningstar brands and products Company Portfolio ...